BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 15173019)

  • 1. Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.
    Dyrskjøt L; Kruhøffer M; Thykjaer T; Marcussen N; Jensen JL; Møller K; Ørntoft TF
    Cancer Res; 2004 Jun; 64(11):4040-8. PubMed ID: 15173019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma.
    Zhang ZT; Pak J; Shapiro E; Sun TT; Wu XR
    Cancer Res; 1999 Jul; 59(14):3512-7. PubMed ID: 10416618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
    Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
    J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder cancer outcome and subtype classification by gene expression.
    Blaveri E; Simko JP; Korkola JE; Brewer JL; Baehner F; Mehta K; Devries S; Koppie T; Pejavar S; Carroll P; Waldman FM
    Clin Cancer Res; 2005 Jun; 11(11):4044-55. PubMed ID: 15930339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proliferative activity and p53 expression in transitional cell carcinoma of the urinary bladder].
    Offner FA; Schäfer G; Hittmair A; Ofner D; Grünewald K; Weyrer K; Mattern D; Eberle J; Mikuz G; Feichtinger H
    Verh Dtsch Ges Pathol; 1993; 77():241-6. PubMed ID: 7511289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of gene expression patterns in superficial and invasive human bladder cancer.
    Thykjaer T; Workman C; Kruhøffer M; Demtröder K; Wolf H; Andersen LD; Frederiksen CM; Knudsen S; Orntoft TF
    Cancer Res; 2001 Mar; 61(6):2492-9. PubMed ID: 11289120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying distinct classes of bladder carcinoma using microarrays.
    Dyrskjøt L; Thykjaer T; Kruhøffer M; Jensen JL; Marcussen N; Hamilton-Dutoit S; Wolf H; Orntoft TF
    Nat Genet; 2003 Jan; 33(1):90-6. PubMed ID: 12469123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A molecular signature in superficial bladder carcinoma predicts clinical outcome.
    Dyrskjøt L; Zieger K; Kruhøffer M; Thykjaer T; Jensen JL; Primdahl H; Aziz N; Marcussen N; Møller K; Orntoft TF
    Clin Cancer Res; 2005 Jun; 11(11):4029-36. PubMed ID: 15930337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
    Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
    Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two molecular pathways to transitional cell carcinoma of the bladder.
    Spruck CH; Ohneseit PF; Gonzalez-Zulueta M; Esrig D; Miyao N; Tsai YC; Lerner SP; Schmütte C; Yang AS; Cote R
    Cancer Res; 1994 Feb; 54(3):784-8. PubMed ID: 8306342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of transitional cell carcinoma using cDNA microarray.
    Mor O; Nativ O; Stein A; Novak L; Lehavi D; Shiboleth Y; Rozen A; Berent E; Brodsky L; Feinstein E; Rahav A; Morag K; Rothenstein D; Persi N; Mor Y; Skaliter R; Regev A
    Oncogene; 2003 Oct; 22(48):7702-10. PubMed ID: 14576834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in gene expression between noninvasive and invasive transitional cell carcinoma of the human bladder using complementary deoxyribonucleic acid microarray: preliminary results.
    Elsamman E; Fukumori T; Ewis AA; Ali N; Kajimoto K; Shinohara Y; Ishikawa M; Takahashi M; Nishitani MA; Baba Y; Kanayama HO
    Urol Oncol; 2006; 24(2):109-15. PubMed ID: 16520272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder.
    Wild PJ; Herr A; Wissmann C; Stoehr R; Rosenthal A; Zaak D; Simon R; Knuechel R; Pilarsky C; Hartmann A
    Clin Cancer Res; 2005 Jun; 11(12):4415-29. PubMed ID: 15958626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder.
    Lazzeri M; Vannucchi MG; Spinelli M; Bizzoco E; Beneforti P; Turini D; Faussone-Pellegrini MS
    Eur Urol; 2005 Oct; 48(4):691-8. PubMed ID: 15992990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A
    Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of vascular endothelial growth factor in transitional cell carcinoma of urinary bladder is correlated with cancer progression.
    Yang CC; Chu KC; Yeh WM
    Urol Oncol; 2004; 22(1):1-6. PubMed ID: 14969795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder.
    Izawa JI; Slaton JW; Kedar D; Karashima T; Perrotte P; Czerniak B; Grossman HB; Dinney CP
    Oncol Rep; 2001; 8(1):9-15. PubMed ID: 11115562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder.
    Elsamman E; Fukumori T; Kasai T; Nakatsuji H; Nishitani MA; Toida K; Ali N; Kanayama HO
    BJU Int; 2006 Jun; 97(6):1202-7. PubMed ID: 16686711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.